Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,445.00
+89.00 (3.78%)
Oct 9, 2026, 4:59 PM CET
Genmab Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Genmab stock has a consensus rating of "Buy" and an average price target of kr 2,592. The average 1-year stock price forecast is 6.03% higher than the current stock price, while the lowest is kr 1,400 (-42.74%) and the highest is kr 3,310 (+35.38%).
Price Target: kr 2,592 (+6.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 13 | 13 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 18 | 17 | 17 |
Financial Forecast
Revenue This Year
4.69B
from 3.72B
Increased by 25.99%
Revenue Next Year
5.48B
from 4.69B
Increased by 16.94%
EPS This Year
12.88
from 17.72
Decreased by -27.32%
EPS Next Year
17.48
from 12.88
Increased by 35.70%
EPS and Forward PE are based on non-GAAP adjusted numbers.